Curium Announces First Commercial Doses of PYLCLARI for Patients with Prostate Cancer in Poland
PYLCLARI® provides solutions to a wider patient group across Poland where there…
Press Release: Sanofi and Regenerons Dupixent approved in Japan for children aged 6 to 11 years with bronchial asthma
Sanofi and Regeneron’s Dupixent approved in Japan for children aged 6 to…
Dupixent (dupilumab) Approved in Japan for Children Aged 6 to 11 Years with Bronchial Asthma
Approval based on global Phase 3 program in children demonstrating Dupixent significantly…
DataGavel Announces Full Acquisition by Renvent Holdings as Platform Emerges as the Defense Bars Advantage
ROSWELL, Ga., Dec. 22, 2025 (GLOBE NEWSWIRE) -- DataGavel, the LegalTech platform…
Mawson Infrastructure Group Inc. Announces Compliance with Nasdaq Continued Listing Requirements
December 22, 2025 14:05 ET | Source: Mawson Infrastructure Group Inc. MIDLAND,…
CreditBlockchain Introduces Limited Ticket Distribution, Helping Fans Celebrate the Ultimate Sporting Event
New York, USA, Dec. 22, 2025 (GLOBE NEWSWIRE) -- CreditBlockchain is giving…
Greenwich LifeSciences Provides Additional Updates on FLAMINGO-01 and Corporate Strategy
STAFFORD, Texas, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq:…
Biosplice Therapeutics Announces First Patient Dosed in InvestigatorInitiated Phase 1 Clinical Trial of Cirtuvivint and Olaparib in BRCA/HRD PlatinumResistant Ovarian Cancer
SAN DIEGO, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Biosplice Therapeutics, Inc. (“Biosplice”),…
Alvotech announces European launch of first-in-market biosimilar to Simponi (golimumab) globally by partner Advanz Pharma
Introduction of AVT05 supported by NHS England tender award in the United…
Bitlock Wallet Confirms Mobile App Launch, Bringing Its All-in-One Crypto Platform to iOS and Android
DUBAI, United Arab Emirates, Dec. 21, 2025 (GLOBE NEWSWIRE) -- Bitlock Wallet,…
